E07-001: Safety and Efficacy Extension Study of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Patients
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Eculizumab
Related studies linked through entity extraction aliases.
An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy Study of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Patients
- Status
- COMPLETED
- Phase
- PHASE2
Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Crossmatch Deceased Donor Kidney Transplant
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Eculizumab to Prevent Antibody-mediated Rejection in ABO Blood Group Incompatible Living Donor Kidney Transplantation
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Eculizumab to Enable Renal Transplantation in Patients With History of Catastrophic Antiphospholipid Antibody Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Complement Inhibition With Eculizumab for the Treatment of Non-Exudative Macular Degeneration (AMD)
- Status
- COMPLETED
- Phase
- PHASE2
An Open Label Study of the Effects of Eculizumab in Neuromyelitis Optica
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Eculizumab Pharmacokinetics/Pharmacodynamics Study in Pediatric/Adolescent Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Status
- COMPLETED
- Phase
- PHASE4
Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Resistant aHUS
- Status
- COMPLETED
- Phase
- PHASE2
Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-Resistant aHUS
- Status
- COMPLETED
- Phase
- PHASE2
Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Sensitive aHUS
- Status
- COMPLETED
- Phase
- PHASE2
Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-sensitive Atypical Hemolytic Uremic Syndrome (aHUS)
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis
- Status
- TERMINATED
- Phase
- PHASE2
Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Cross Match Living Donor Kidney Transplant
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Efficacy Study of Eculizumab in Patients With Mild Allergic Asthma
- Status
- COMPLETED
- Phase
- PHASE2
The Paroxysmal Nocturnal Hemoglobinuria Early Access Treatment Protocol
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Eculizumab to Treat Paroxysmal Nocturnal Hemoglobinuria
- Status
- COMPLETED
- Phase
- PHASE3
Study Using Eculizumab in Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients
- Status
- COMPLETED
- Phase
- PHASE3
Extension Study of Eculizumab in Patients With Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Status
- COMPLETED
- Phase
- PHASE3